A recent McKinsey survey revealed that only 10%–14% of companies consistently deploy generative AI in their marketing and sales initiatives. Why, in a function that seemingly stands to gain the most ...

Despite being a cornerstone of cancer treatment advancement, clinical trials remain inaccessible for many patients because of structural, socioeconomic, and systemic barriers. In this ...